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Interferon-g-treated renal tubular epithelial cells induce allospecific
tolerance. Following organ transplantation, tissue parenchymal cells com-
monly express major histocompatibility complex (MHC) class II molecules
as a result of local cytokine release, and thus acquire the capacity to
present donor MHC alloantigens to alloreactive CD41 T cells. The
consequences of such a presentation are likely to be relevant in the
induction of tolerance to the transplanted tissues, and this has been
reported in animal models of transplantation and in humans. In this study,
the consequences of antigen presentation by interferon-g (IFN-g)-treated
human renal tubular epithelial cells (RTEC) to resting and activated
CD41 T cells were investigated. Allogeneic RTEC were unable to
stimulate proliferation by peripheral blood CD45 RA1 or RO1 CD41 T
cells from three HLA-mismatched responders. The response to RTEC
was partially reconstituted by the addition of murine L cell transfectants
expressing human B7.1 (DAP.3-B7), suggesting that the failure of RTEC
to stimulate a primary alloresponse was due, at least in part, to a lack of
costimulation. T cell clones dependent on B7-mediated co-stimulation
also did not respond to peptide presented by RTEC. Most importantly,
this lack of reactivity was accompanied by the induction of nonresponsive-
ness. Incubation with allogeneic, DR-expressing RTEC induced allospe-
cific hyporesponsiveness in both CD45RA1 and RO1 T cells. Similarly,
overnight incubation with antigen-pulsed RTEC induced nonresponsive-
ness in the B7-dependent T cell clones. These results suggest that MHC
class II expression on RTEC may contribute to the induction of an
allospecific nonresponsiveness following organ transplantation.
Observations made in the context of experimental models of
transplantation have suggested that the immunogenicity of allo-
geneic tissues correlates with the content of bone marrow-derived
specialized antigen-presenting cells (APC). This conclusion is
based on the finding that depletion of bone marrow-derived APC
leads to allograft acceptance in some MHC incompatible strain
combinations. For example, murine tissue grafts such as thyroid
[1, 2] or pancreatic b cells [3] are not rejected when transplanted
following an in vitro culture period that depletes the tissues of
bone marrow-derived cells (passenger leukocytes). Similarly, in a
rat model, F1 kidney allografts that were transplanted into a
parental strain recipient under the cover of a short course of
immunsuppresesion were not rejected when the immunosuppres-
sion was withdrawn. Furthermore, when these F1 kidney allografts
were re-transplanted into a second parental strain animal they
were accepted in the absence of any immunosuppression [4]. In
contrast, if the retransplanted grafts were reconstituted with
donor strain dendritic cells, they were rejected at the same rate as
primary grafts between the same donor and recipient strains [5, 6].
In some of these models, rejection could also be induced by
injecting lymphoid cells of donor origin in the early post-graft
period [2]. However, this becomes more difficult with time,
suggesting the emergence of a population of regulatory cells that
maintain the tolerant state. Indeed, the prolonged residence of an
allograft induces a state of profound donor-specific tolerance in
many of these models, such that the recipient harboring an
allograft will accept a challenge graft, replete with passenger cells,
from the same donor strain [7].
We have recently reported data from human renal transplant
recipients that suggests that the prolonged presence of an allo-
graft can induce donor-specific T cell hyporesponsiveness in
humans. In approximately one third of the patients with function-
ing renal transplants mismatched for several HLA antigens the
frequency of anti-donor, interleukin-2-secreting T cells was de-
pressed compared to the frequencies measured against third party
cells [8, 9]. The same observations have been made in cardiac
transplant recipients (Hornick and Lechler, unpublished observa-
tions).
Although the mechanisms whereby an allograft induces allospe-
cific tolerance are not fully understood, they may reflect the
consequences of alloantigen presentation by tissue parenchymal
cells. It has become clear that the activation of IL-2-secreting T
cells requires the delivery of cognate and costimulatory signals by
the APC. The receipt of cognate signals in the absence of
costimulation is usually not a neutral event for the T cell, but
rather alters the subsequent reactivity of the T cell by inducing
apoptosis, anergy, or the secretion of an altered pattern of
cytokines. In addition, in a rat kidney transplant model, major
histocompatibility complex (MHC)-class II-expressing renal tubu-
lar epithelial cells (RTEC) have been shown to induce a state of
proliferative non-responsiveness in alloreactive T cell clones [10].
However, the consequences of allorecognition of parenchymal
cells by resting CD41 T cells are less clearly defined.
In this study, the effects of antigen presentation by RTEC to
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resting CD41 peripheral blood T cells and to established T cell
clones were analyzed and compared. The results show that
interferon gamma (IFN-g)-treated RTEC induce specific nonre-
sponsiveness in B7-dependent naive and previously activated T
cells. These data support the hypothesis that parenchymal cell




The synthetic influenza virus hemagglutinin (HA) peptides
(HA307-319 and HA100-115) were synthesized by the Imperial
Cancer Research Fund (ICRF) Peptide Unit and kindly provided
by Dr. Hans Stauss.
Monoclonal antibodies and fusion proteins
The following antibodies were used for staining as hybridoma
supernatants: L243 (anti-DRa; American Type Culture Collec-
tion, ATCC, Rockville, MD, USA), TS2/9 (anti-human LFA-3;
ATCC), 6.5B5 (anti-ICAM-1; kindly provided by Dorian
Haskard) and BU63 antibody (anti-B7.2; kindly provided by Peter
Beverly, ICRF, London, UK). Anti-B7/BB1 (anti-B7.1) was pur-
chased from Becton Dickinson (Cowley, Oxford, UK).
The following purified antibodies were used for the enrichment
of CD41 T cells: Leu19 (anti-CD56; Becton Dickinson), mouse
anti-human Ig (Fab-specific; Sigma). The OKT8 (anti-human
CD8; ATCC) and L243 (anti-DRa; ATCC) antibodies were
purified from culture supernatant on protein A-Sepharose beads
by standard methods. Eluted antibody was dialyzed against three
changes of PBS. The B7/21 (anti-DP; ATCC) and L2 (anti-DQ)
[11] monoclonal antibodies (mAbs) were purified as described
above.
The mAbs UCHL1 (anti-CD45RO; gift of P. Beverley) [12] and
SN 130 (anti-CD45RA; gift of G. Janossy, Royal Free Hospital,
London, UK) [13] were purified as described above and used for
isolation of CD4 T cell subsets.
The fusion protein CTLA-4-Ig was obtained from the superna-
tant of COS cell transfectants kindly provided by Peter Lane
(Basel Institute for Immunology, Basel, Switzerland) [14].
Renal cell preparation and culture
Human renal tissues were obtained from nephrectomy speci-
mens and were preserved in RPMI 1640 medium (Gibco BRL,
Paisley, UK), at 4°C before processing. Cortical material was
dissected into 2 mm3 blocks and washed twice in phosphate
buffered saline (PBS). It was digested in a solution of collagenase
(1 mg/ml; Sigma Chemicals Company Ltd, Poole, Dorset, UK) for
two hours at 37°C in a humid incubator. Cortical material was
washed twice in PBS and non-digested material was incubated for
a further one hour in trypsin-ethylenediaminetetraacetic acid
(EDTA; Flow Labs) under the same conditions. The renal tubular
epithelial cells obtained from the enzymatically digested tissues
were washed and resuspended in Medium 199 (Sigma) containing
5% fetal calf serum (FCS; Globefarm, Cheshire, UK), 2 mM
L-glutamine, 50 IU/ml penicillin and 50 mg/ml streptomycin,
insulin transferrin selenite (5 mg/ml; Sigma), triiodiothyronine
(3 3 1028 M; Sigma) and hydrocortisone (5 3 1028 M; Sigma) and
were cultured in 25 and 75 cm2 flasks (Greiner Labortechnik Ltd,
Dursley, UK). After 16 hours the RTEC adherent layer was
washed extensively in RPMI and fresh medium was added. After
three days the cells were harvested with 0.05% trypsin (Gibco)
and stored in liquid nitrogen and, when required, cultured in
Medium 199 containing 20% FCS, 2 mM L-glutamine, 50 IU/ml
penicillin and 50 mg/ml streptomycin, insulin transferrin selenite
(5 mg/ml; Sigma), triiodiothyronine (3 3 1028 M; Sigma) and
hydrocortisone (5 3 1028 M; Sigma), either with or without IFN-g
(500 U/ml). Confirmation of the epithelial lineage of the cultures
obtained was achieved by staining with an anti-cytokeratin mAb
(DAKO-CK1, LP34).
Cell lines
Epstein Barr virus (EBV)-transformed lymphoblastoid B cell
lines (B-LCLs), from the 10th International Histocompatibility
Workshop, were cultured in RPMI 1640 tissue culture medium
(ICN, Flow, Thame, UK) supplemented with 10% FCS, 2 mM
L-glutamine, 50 IU/ml penicillin, and 50 mg/ml streptomycin in 25
cm2 flasks, and were regularly passaged.
DAP.3-B7 transfectants were produced by co-transfection with
a B7.1 cDNA in the pcExV-3 vector (gift from Mark Jenkins,
University of Minnesota, Minneapolis, MN, USA) and a hygro-
mycin B resistance gene. Cells expressing the transfected genes
were selected in medium containing 200 mg/ml hygromycin B
(ICN Biochemical). The fibroblast line was maintained in DMEM
tissue culture medium (Flow Laboratories, Irvine, Ayrshire, UK)
supplemented with 10% FCS, 0.2% sodium bicarbonate, 2 mM
L-glutamine, 50 IU/ml penicillin and 50 mg/ml streptomycin, and
hygromycin B 200 mg/ml (Sigma Chemical Co.) to maintain
expression of the transfected genes. Cells were grown in 25 cm2
flasks, and passaged, following trypsinization, once weekly.
The interleukin (IL)-2-dependent murine T cell line CTLL-2
(European Collection of Animal Cell Cultures, Salisbury, UK)
was cultured in RPMI 1640 medium, supplemented with 2 mM
L-glutamine, 50 IU/ml penicillin, and 50 mg/ml streptomycin, 10
U/ml of human recombinant IL-2 (rIL-2; Boehringer, Mannheim,
Germany) and 10% FCS in 25 cm2 flasks and was subcultured
every three days.
The IL-4-dependent murine cell line CT.h4S [15], transfected
with a cDNA encoding the human IL-4 receptor (gift of W. Paul,
Bethesda, MD, USA) was cultured in RPMI 1640 medium,
supplemented with sodium bicarbonate (0.24% final concentra-
tion) 2 mM L-glutamine, 50 IU/ml penicillin, and 50 mg/ml
streptomycin, human recombinant IL-4 (rIL-4, 100 U/ml; Gen-
zyme, West Malling, UK) and 10% FCS. The cells were cultured
in 25 cm2 flasks and were subcultured every three days. Prior to
use in a proliferation assay the CT.h4S cells were washed twice
and kept on ice.
Purification of CD41 CD45RO1 and CD45RA1 T cells
Peripheral blood mononuclear cells (PBMC) were obtained by
Ficoll-Hypaque (Pharmacia Biotech., St. Albans, UK) centrifuga-
tion of heparinized blood, washed twice and resuspended in
RPMI 1640 medium supplemented with 10% FCS, 2 mM glu-
tamine, 50 IU/ml penicillin, and 50 mg/ml streptomycin. The cell
preparation was then depleted of adherent cells by two 45-minute
periods of adherence to plastic on tissue culture dishes at 37°C.
The non-adherent cells were subsequently collected and incu-
bated with a cocktail of purified mAbs (L243, OKT8, Leu19,
mouse anti-human Ig and UCHL1 or SN130) at saturating
concentrations for 30 minutes at 4°C. The cells were then washed
twice to remove excess antibody and the antibody-bound cells
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removed by magnetic immunodepletion. Briefly, mAb-treated
cells were incubated with magnetic microbeads (Miltenyi Biotec
GmbH, Bergisch Gladbach, Germany) coated with sheep anti-
mouse Ig for 15 minutes at 4°C and bead/mAb-coated cells were
removed by passage through a magnetic column (MiniMAC
system; Miltenyi). The purified cells were resuspended in medium
ready for the proliferation assay, and accessory cell contamination
was assessed by flow cytometric analysis and by measurement of
proliferation in response to 2 mg/ml phytohemagglutinin (PHA) in
a 48-hour proliferation assay.
T cell clones
Two sets of T cell clones, LR61, LR67, LR69 and LR30, LR34,
LR47, LR51, LR53, specific for the HA peptide 307 to 319 and
restricted by DRB5*0101 and DRB1*0401, respectively, were
derived from PBMC isolated from a DR15,4 individual by stim-
ulating PBMC with purified influenza HA peptide (5 mg/ml). The
clones were maintained in culture by weekly stimulation with
autologous PBMC, HA peptides and rIL-2, in RPMI 1640 me-
dium supplemented with 10% human serum, 2 mM L-glutamine,
50 IU/ml penicillin, and 50 mg/ml streptomycin. Accessory cell
free preparations of T cells were prepared as described before
[16]. Briefly, T cells were reseeded into new 24-well tissue culture
plates on days 3 and 6 after restimulation in order to remove
adherent cells. For use in experiments the cells were further
purified by isolation on Ficoll-Paque seven days after restimula-
tion and were washed five times by slow speed centrifugation (210
g, 5 min) before use.
Flow microfluorimetric analysis
For flow microfluorimetric analysis, 5 3 105 B-LCL or RTEC
were incubated with the indicated mAbs at 4°C for 30 minutes.
After washing twice in phosphate-buffered saline with 2.5% FCS,
the cells were incubated for a further 30 minutes at 4°C with 100
ml of 1:50 dilution of fluorescinated sheep anti-mouse Ig (Amer-
sham International, Amersham, UK). After two additional
washes, stained cells were analyzed using the EPICS Profile Flow
Cytometer (Coulter Eletronics, Luton, UK).
T cell proliferation assays
T cell clones (104 cells/well) were cultured in the presence of
B-LCLs, treated with 120Gy X-irradiation, or RTEC, treated with
30Gy X-irradiation, or with mitomycin-C-treated DAP.3 cell lines,
in flat-bottomed microtiter plates, in a total volume of 200 ml. For
antigen-specific responses, the antigen presenting cells were pre-
pulsed with antigenic peptides overnight, and then washed to
remove any soluble peptide. In some experiments DAP.3-B7 cells
were added to the cultures. Wells were pulsed with 1 mCi of
3H-TdR (Amersham International) after 48 hours and the cul-
tures harvested onto glass fiber filters 18 hours later. Proliferation
was measured as 3H-TdR incorporation by liquid scintillation
spectroscopy. The results are expressed as the mean of triplicate
cultures. Standard errors were routinely , 10%.
For primary MLR assays, purified human CD41 T cells (105
cells/well) were cultured with different numbers of irradiated
stimulator cells, as indicated in the Figure legends, in flat-
bottomed plates (ICN Flow) for six days. Wells were pulsed with
1 mCi of 3H-TdR 20 hours before the end of the culture.
Proliferation was measured and expressed as described above.
Three stage cultures for tolerance induction in peripheral blood
T cells
Purified CD41 CD45RO1 or CD45RA1 T cells (106/well) were
plated out in 24 well plates in the presence of allogeneic IFN-g-
treated RTEC (2 3 105/well) with or without DAP.3-B7 cells (1:1
ratio), a second population of allogeneic g-IFN-treated RTEC
expressing a different HLA-DR allele (2 3 10 5/well) and B-LCL
expressing the same HLA-DR type as the first RTEC population
(2 3 105/well). After five days the T cells were harvested, purified
by isolation on a Ficoll-Paque gradient and washed five times by
low speed centrifugation (210 g, 5 min). Recovered T cells from
each culture were subsequently re-stimulated (2 3 104/well) with
a B-LCL (2 3 104/well) expressing the same HLA-DR allele as
the first population of RTEC and a B-LCL expressing the same
HLA-DR allele as the second population of RTEC (2 3 104/well).
In the rechallenge cultures containing B-LCL, monoclonal an-
ti-DP and anti-DQ antibodies were added at a final concentration
of 2 mg/ml. The T cells were also re-challenged with the RTEC (2
3 104/well) in the presence of the DAP.3-B7 transfectants (2 3
104/well). After 3, 7 and 10 days cells were pulsed with 1 mCi
3H-TdR. Proliferation was measured and expressed as described
above.
Two stage cultures for tolerance induction in T cell clones
T cell clones were plated out in 24-well plates in the presence of
peptide-prepulsed irradiated RTEC in a total volume of 500 ml. In
addition, T cell clones were also cultured alone or in the presence
of HA peptides (10 mg/ml), as previously described [16]. After
overnight incubation, the cells were harvested, washed exten-
sively, and used in proliferation assays as described above. To
“rest” the T cells, they were left for three days in the presence of
a submitogenic dose of rIL-2.
CTLL and CT.h4S assays
Culture supernatants were collected and transferred into two
sets of 96-well round-bottomed microtiter plates as triplicate
cultures for measurement of IL-4 and IL-2. The plates were stored
at 220°C until used. In each well either 3 3 103 CTLL or 5 3 103
CT.h4S cells were added. In each experiment a standard titration
for rIL-2 and/or rIL-4 was included. After 8 and 24 hours of
incubation, respectively, wells were pulsed with 1 mCi of 3H-TdR
(Amersham International). After 18 hours the cultures were
harvested onto glass fiber filters and 3H-TdR incorporation was
measured by liquid scintillation spectroscopy, as described above.
RESULTS
Characterization of renal tubular epithelial cells
Renal tubular epithelial cells were first stained for cytokeratin,
a marker for epithelial cells, using the monoclonal antibody
DAKO-CK1, LP34, to determine their purity. All the cells stained
positively with this antibody, confirming the epithelial lineage of
the cells (data not shown). Prior to the experiments, RTEC were
induced to express MHC class II molecules by culture in the
presence of IFN-g (103 U/ml) for four days. This led to levels of
MHC class II molecule expression approximately fivefold lower
than that of B-LCL (Fig. 1 B, H). In addition, the effect of IFN-g
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treatment on the expression of accessory molecules that are
known to contribute to T cell reactivity was examined. Following
treatment with IFN-g, ICAM-1 expression was up-regulated,
while LFA-3 expression was unaffected (data not shown). The
level of ICAM-1 and LFA-3 expression on the induced RTEC was
comparable to that on B-LCL (Fig. 1, E, F, M, N). No detectable
expression of the B7 family of molecules was seen using either
anti-B7/BB1 mAb (Becton Dickinson), specific for B7.1, or BU63
specific for B7.2 on RTEC (Fig. 1, I, L). The expression of B7.1
and B7.2 molecules on B-LCL is shown in Figure 1, panels C and
D.
Major histocompatibility complex class II-expressing renal
tubular epithelial cells are unable to stimulate a primary
alloresponse
The ability of IFN-g-treated RTEC to induce proliferation by
human CD41 T cells from three HLA DR-mismatched respond-
ers was analyzed. Highly purified CD41 T cells failed to prolifer-
ate to DR-expressing RTEC in a five day culture. On the contrary,
they proliferated strongly to B-LCL expressing the same HLA-
DR4 alloantigen. The results from a representative experiment
are shown in Figure 2A. To determine whether the failure to
respond to RTEC was due to the lack of B7 molecule expression,
CD41 T cells were co-cultured with RTEC in the presence of a
murine fibroblast cell line transfected with a cDNA clone encod-
ing human B7.1 (DAP.3-B7). As shown in Figure 2B, the addition
of DAP.3-B7 reconstituted the low level proliferation by the
CD41 T cells to RTEC. The involvement of B7 in the trans-
costimulation provided by DAP.3-B7 was further demonstrated by
the finding that the proliferation was inhibited by the addition of
CTL4-Ig. In addition, an anti-DR antibody, L243, also inhibited
the response (Fig. 2). These results provide evidence that the
failure of RTEC to stimulate a primary alloresponse is due to a
lack of B7-mediated costimulation.
Co-culture with interferon-g-treated allogeneic renal tubular
epithelial cells induces allospecific nonresponsiveness in resting
CD41 CD45RO1 and CD45RA1 T cells
It has previously been shown, using antibody blocking or
transfectant APC, that specific recognition in the absence of
B7-mediated costimulation can lead to a state of non-responsive-
ness in resting T cells [17, 18]. In a previous study we have
observed that memory (CD45RO1) and naive (CD45RA1) T
cells differ in their susceptibility to the induction of unresponsive-
ness by MHC class II-expressing endothelial cells [19].
The effect of allorecognition of RTEC by resting CD45RO1 and
CD45RA1 CD41 T cell subpopulations was then examined in a
three step culture model. Purified CD41 T cell subsets were co-
cultured with two populations of allogeneic IFN-g-treated RTEC
and a B-LCL expressing the same HLA DR alleles as the first
population of RTEC. After five days the T cells were harvested and
purified as described in the Methods section. T cells from each
culture were subsequently re-challenged in a proliferation assay with
both populations of allogeneic B-LCLs. A representative example of
a series of criss-cross experiments is shown in Figure 3. After being
cultured in the presence of MHC class II-expressing RTEC, the
ability of both CD41 CD45RO1 and CD45RA1 T cells to respond
to the B-LCL expressing the same DR type as the RTEC was
markedly reduced, while the T cells retained the ability to respond to
B-LCL expressing third party DR antigens (Fig. 3). In contrast, both
Fig. 2. Renal tubular epithelial cells (RTEC)
are unable to stimulate a primary Fspell out
(MLR). Peripheral blood CD41 T cells were
purified as described in the Methods section.
CD41 T cells (105 cells/well) were cultured with
different numbers of HLA-DR4-expressing B-
LCL (E), and RTEC pretreated () or not ()
with IFN-g (104 U/ml). The results are shown
in (A). (B) CD41 T cells were cultured either
with interferon-g (IFN-g)-treated RTEC ()
alone or in the presence of DAP.3-B7 cells ().
In addition, CD41 T cells were co-cultured with
RTEC and DAP.3-B7 cells in the presence of
either anti-DR monoclonal antibody (mAb; f)
or CTLA4-Ig (M). The plates were incubated
for six days and 3H-TdR was added for the last
18 hours. Proliferation is shown as mean cpm
of triplicate cultures, corrected for background
proliferation of stimulator cells alone (Dcpm).
Standard errors were routinely , 10%.
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Fig. 1. Interferon-g (IFN-g)-treated renal tubular epithelial cells (RTEC) express high levels of HLA-DR, but lack expression of B7.1 and B7.2
molecules. (A and F) Negative controls (fluoresceinated sheep anti-mouse Ig alone) for B-LCL and RTEC, respectively, 96 hours after IFN-g treatment.
(B through F) B-LCL were stained with different monoclonal antibodies (mAbs). The same mAbs were used with RTEC from panels H to N. The
following mAbs were used: anti-DR (L243) (panels B and H); anti-B7.1 (B7/BB1; panels C and I); anti-B7.2 (BU63; panels D and L); anti-LFA-3 (TS2/9;
panels E and M) and anti-ICAM-1 (6.5B5; panels F and N).
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CD41 T cell subsets were primed following culture with either RTEC
plus the DAP.3-B7 transfectants, or a B-LCL, and proliferated in the
re-challenge cultures with a peak of response at day 3 to the B-LCL
expressing the same DR allele as the RTEC and the B-LCL used for
priming (Fig. 3). Anti-DP and anti-DQ mAbs were included in the
re-challenge cultures containing B-LCL to exclude possible effects of
DP and DQ differences between the RTEC and the B-LCL.
Renal tubular epithelial cells are unable to stimulate “B7-
dependent” T cell clones
The antigen presenting function of RTEC was further analyzed
by testing their capacity to stimulate the proliferation of estab-
lished human T cell clones restricted by ether DRB5*0101 or
DRB1*0401 and specific for a peptide of HA (HA 307-319).
Fig. 3. Allorecognition of renal tubular epithe-
lial cells (RTEC) by CD45RA1 and CD45RO1
CD41 T cells renders them unresponsive to a
subsequent re-challenge. Purified CD41 T cell
subsets, CD45RA1 (A) and CD45RO1 (B),
were co-cultured with allogeneic interferon-g
(IFN-g)-treated RTEC 1 (DR17) alone or in
the presence of DAP.3-B7 cells, RTEC2
(DR15) and B-LCL 1 (DR17) as described in
the Methods section. T cells from each culture
were subsequently re-challenged in a prolifera-
tion assay with B-LCL 1 (104 cells/well) and
B-LCL 2 (DR15) (104 cells/well). In the re-chal-
lenge cultures containing B-LCL, the B7.21
(anti-DP) and L2 (anti-DQ) monoclonal anti-
bodies (mAbs) were added in order to exclude
any effect of mismatching between the TFC
and the B-LCL at these loci. Re-challenge cul-
tures were harvested on days 3, 7 and 10 in or-
der to detect responses with primary versus sec-
ondary kinetics. 3H-TdR was added for the last
18 hours of culture. Results are expressed as
the mean cpm for triplicate cultures 3 1023,
corrected for background proliferation of both
T cells and stimulators alone (D cpm). Standard
errors were routinely , 10%. The responder
and stimulator cells present in the initial culture
are indicated above each pair of graphs. The
stimulator cells used in the re-challenge step
are indicated within each graph.
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Fig. 4. Renal tubular epithelial cells (RTEC)
can stimulate antigen-specific B7-independent,
but not B7-dependent, T cell clones. Interfer-
on-g (IFN-g)-treated RTEC (F) and B-LCL
(E) were pulsed overnight with different doses
of hemagglutinin (HA) peptide. The HA-spe-
cific and DRB5*0101-restricted T cell clones
(A) LR61, (B) LR67, (C) LR69 and HA-spe-
cific and DR4-restricted T cell clones, (D)
LR30, (E) LR34, (F) LR47, (G) LR51, (H)
LR53 (104 cells/well), all specific for HA307-
319, were cultured with either peptide-pre-
pulsed RTEC or B-LCL (104 cells/well). The
plates were incubated for three days and 3H-
TdR was added for the last 18 hours. Prolifera-
tion was assessed and reported as described in
the legend to Figure 3.
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Fig. 5. Renal tubular epithelial cells (RTEC)
can stimulate interleukin (IL)-2 production by
antigen-specific B7-independent, but not B7-
dependent, T cell clones. Interferon-g (IFN-g)-
treated RTEC (F) and B-LCL (E) were pulsed
overnight with different doses of peptides.
Hemagglutinin (HA)-specific and DRB5*0101-
restricted T cell clones (A) LR61, (B) LR67,
(C) LR69 and HA-specific and DR4-restricted
T cell clones (D) LR30, (E) LR34, (F) LR47,
(G) LR51, (H) LR53 (104 cells/well), all specific
for HA307-319, were cultured with either pep-
tide-prepulsed RTEC or B-LCL (104 cells/well).
After 24 hours supernatants were collected and
IL-2 production was tested using CTLL-2 cells
as described in the Methods section. Prolifera-
tion was assessed and reported as described in
the legend to Figure 3.
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T cells were purified as described in the Methods section, and
their proliferation to the two RTEC lines (RTEC 1, DR15 and
RTEC 2, DR4,13) or to DR15 or DR4 B-LCL, prepulsed with
different doses of peptides, was measured. The results shown in
Figure 4 suggest that the T cell clones can be divided into two
groups based on their capacity to respond to peptide presented by
pre-pulsed RTEC. Clones LR61 (DRB5*0101-restricted) and
LR34 (DR4-restricted) showed no response, even at high peptide
concentrations. The other five T cell clones showed proliferation
to peptide presented by RTEC, although substantially higher
concentrations of peptide were required to achieve comparable
levels of T cell proliferation (Fig. 4). The T cell clones that
proliferated in response to the RTEC also produced IL-2 without
IL-4, clones LR30 and LR47 or both IL2 and IL4 clones LR67,
LR69, LR51 and LR53, following antigen-specific stimulation
(Figs. 5 and 6).
Peptide presentation by renal tubular epithelial cells induces
nonresponsiveness in B7-dependent T cell clones
It has been shown before that specific recognition of peptide/
MHC class II complexes in the absence of costimulation can lead
to a state of non-responsiveness in IL-2-secreting T cell clones [20,
21]. We tested this possibility using the T cell clones that were
unable to proliferate in response to peptide presented by RTEC.
For this purpose, T cell clones LR61 and LR34 were purified as
previously described [16] and then cultured overnight with pep-
tide-prepulsed RTECs. T cells were then washed and tested for
their capacity to proliferate and to secrete IL-2 in response to
peptide presented by B71 APC, namely B-LCL. The results are
shown in Figure 7. Recognition of the specific peptide presented
by RTEC inhibited proliferation and IL-2 production by both
clones in response to B-LCL. The proliferation and the release of
IL-2 in response to B-LCL was reduced only when the two clones
were cultured overnight with relevant peptide-prepulsed RTEC
(HA307-319). Neither clone produced IL-4 before or after the
induction of nonresponsiveness.
DISCUSSION
In this study the effects of antigen presentation by renal tubular
epithelial cells to CD41 T cells were investigated. The ability of
RTEC to induce proliferation and IL-2 production by human T
cells was found to correlate with their dependence on B7-
mediated costimulation. Major histocompatibility complex class
II-expressing RTEC were unable to induce primary alloprolifera-
tion by resting CD41 T cells of either the memory or naive
phenotype. They were also unable to induce proliferation or IL-2
release by peptide-specific, B7 costimulation-dependent, T cell
clones. Recognition of antigen by all three of these T cell
populations on RTEC led to the induction of nonresponsiveness.
Previous studies on the antigen presenting properties of RTEC in
the rat have reached similar conclusions [10]. In the human
system, Kirby and colleagues reported that RTEC are capable of
inducing allospecific tolerance in peripheral blood T cells [22, 23].
For these experiments whole peripheral blood mononuclear cells
were used as the responder population, and it is not clear why
Fig. 6. Renal tubular epithelial cells (RTEC)
can also stimulate interleukin (IL)-4 produc-
tion by B7-independent antigen-specific Th0 T
cell clones. Interferon-g (IFN-g)-treated RTEC
(F) and B-LCL (E) were pulsed overnight with
different doses of peptide. Hemagglutinin
(HA)-specific and DRB5*0101-restricted T cell
clones (A) LR67, (B) LR69, and HA-specific
and DR4-restricted T cell clones (C) LR51, (D)
LR53, all specific for HA307-319 (104 cells/
well), were cultured with either peptide pre-
pulsed-RTEC or B-LCL (104 cells/well). After
24 hours supernatants were collected and IL-4
production was tested using CTh.4S cells as de-
scribed in the Methods section. Proliferation
was assessed and reported as described in the
legend to Figure 3.
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contaminating specialized APC failed to provide bystander co-
stimulation. When used as APC for established murine T cell
clones, Rubin-Kelly and Jevnikar observed that IFN-g-treated
RTEC were incapable of inducing proliferation, which led to the
induction of a nonresponsive state [24]; however, the effects of
epithelial cell presentation to resting peripheral blood T cells were
not examined. In the present study, care was taken to define both
the differentiation stage and the costimulation requirements of
the T cell populations analyzed. In contrast to resting memory and
naive T cells and B7-dependent primed T cells, a cohort of T cell
clones was identified that did not require B7-mediated signals in
order to proliferate and produce IL-2 following cognate recogni-
tion of RTEC. Prolonged in vitro culture may be responsible for
the emergence of B7-independent T cells. It remains to be
established whether the phenomenon of B7-independence arises
in vivo.
The findings described here might help to shed light on the
observation that the prolonged residence of allografted tissues can
induce a profound state of donor-specific nonresponsiveness in
experimental models of organ transplantation and in humans. It is
well established that removal of bone marrow-derived, specialized
APC from rodent organ allografts leads to a marked reduction in
the immunogenicity of the transplanted tissue [4–6]. Indeed, in
some rat strain combinations “passenger cell”-depleted kidney
allografts are accepted indefinitely without the need for any
immunosuppression [4, 5]. Furthermore, the prolonged residence
of accepted allografts has been shown to induce a state of
profound donor-specific tolerance in mice and rats [7]. We have
recently observed that a related phenomenon occurs in human
renal transplant recipients, in that the frequencies of IL-2-
secreting helper T cells specific for donor HLA-DR antigens were
markedly reduced in approximately one third of the patients
studied [8, 9]. Given that the epithelial cells of renal allografts are
commonly observed to express MHC class II molecules following
transplantation [25], our findings may represent the in vitro
correlate of these in vivo observations.
The mechanisms of T cell tolerance induced by the prolonged
residence of an allograft remain a matter of debate. It has been
suggested that the development of tolerance to an allograft
depends upon the establishment of a state of donor microchimer-
ism, as often observed following liver transplants [26, 27]. This
phenomenon has been proposed to account for the relative
resistance of liver transplants to chronic rejection. If chimerism is
required, attempts to deplete transplanted tissues of donor bone
marrow-derived “passenger” cells are misguided. However, the
precise mechanism by which microchimerism can mediate pro-
longed graft survival is not clear. In addition, we have failed to
establish a correlation between the detection of donor cell chi-
merism and decreased frequencies of donor-specific IL-2-secret-
ing T cells in kidney transplant patients (Mason and Lechler,
unpublished observations). If, on the other hand, the parenchymal
cells of the transplanted organ lack immunogenicity and have the
Fig. 7. Antigen presentation by peptide-pre-
pulsed interferon-g (IFN-g)-treated renal tubu-
lar epithelial cells (RTECs) inhibits prolifera-
tion and interleukin (IL)-2 production by
costimulation-dependent T cell clones. The pro-
liferation (A and C) and production of IL-2 (B
and D) by clone LR61 (DRB5*0101-restricted)
and clone LR34 (DR4-restricted) after over-
night incubation with peptide-pulsed RTECs to
peptide-prepulsed B-LCL is shown. T cells (106/
ml) were cultured under different conditions:
with IFN-g-treated RTEC prepulsed with 10
mg/ml of either the relevant (F), or the irrele-
vant peptide (E), or in medium alone () in 24
well plates. After overnight incubation the T
cells were collected, washed and cultured with
peptide-prepulsed B-LCL. After 24 hours the
supernatants were collected and the IL-2 pro-
duction was tested using the CTLL-2 cells, as
described in the Methods section.
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effect of inducing donor-specific T cell tolerance, the allograft
may well have the capacity to induce tolerance in recipient T cells
with direct allospecificity for the transplanted MHC alloantigens.
This leaves the question open as to what immunological
mechanisms are responsible for the indolent process of chronic
rejection. One possibility is that this reflects the activity of T cells
with indirect allospecificity [5, 6, 28–30]. Such T cells will be
continuously activated by specialized recipient APC that are rich
in costimulation, so that there is no “natural” means of tolerance
for indirect pathway T cells. Improving the long-term acceptance
of allografts is likely to require the design of strategies to induce
tolerance in T cells with indrect allospecificity for the transplanted
antigens.
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